Target intelligence / Profile preview

SH3 domain-containing protein 19 (SH3D19)

Target
SH3D19
Molecular classification
Other (Modular adaptor protein containing multiple SH3 domains), Scaffold/adaptor protein (involved in protein–protein interactions via SH3 domains)[2][7]
01

Overview

SH3 domain-containing protein 19 (SH3D19) is a protein encoded by the SH3D19 gene in humans and contains multiple Src homology 3 (SH3) domains, which are modular domains critical for mediating protein–protein interactions via binding to proline-rich motifs on target proteins[2][3][7]. SH3D19 interacts with proteins such as EBP and members of the ADAM protein family, suggesting a role in modulating the signaling pathways associated with EGFR-ligand shedding[2][5][7]. It may also participate in suppression of Ras-mediated cellular transformation, regulation of cell morphology, and cytoskeletal organization, and is implicated in various vesicle trafficking processes[2][5]. There are no well-characterized drug interactions, biomarker use, or known therapeutic applications for this protein. Its relevance to disease appears limited to some reported associations, such as selective IgG deficiency, but it is not considered a canonical therapeutic target.

Other names
SH3D19EBPDKFZp434D0215EVE1KrynSH3P19Eve-1ADAM-binding protein Eve-1EEN-binding proteinEEN binding proteinSH3 domain protein D19
02

Biological functions

Regulation of ADAM (A disintegrin and metalloprotease) family proteins in EGFR-ligand shedding[2][5][7]Suppression of Ras-induced cellular transformation and Ras-mediated activation of ELK1[2][5]Regulation of cell morphology and cytoskeletal organization[2][5]Protein-protein interaction via proline-rich region binding[2]Possible involvement in vesicle-mediated transport and trans-Golgi network vesicle budding[2]
03

Disease associations

Selective IgG deficiency disease (reported association)[2]Other (related to cell signaling pathways, but no direct implication as a driver in oncology, inflammation, etc., in the current literature)

Beyond the preview

Go deeper on SH3 domain-containing protein 19 (SH3D19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH3 domain-containing protein 19 (SH3D19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call